Explore
13D/13G Activist Filings
118,727 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | INO | Inovio Pharmaceuticals, Inc. | Alyeska Investment Group, L.P. | 13G/A | 6.0% | 4.0M |
| Feb 17, 2026 | SRZN | Surrozen, Inc. | RA Capital Management, L.P. | 13G/A | 9.2% | 872K |
| Feb 17, 2026 | SFIX | Stitch Fix, Inc. | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 16.4% | 19.5M |
| Feb 17, 2026 | COGT | Cogent Biosciences, Inc. | Commodore Capital LP | 13G/A | 1.8% | 2.8M |
| Feb 17, 2026 | VCTR | Victory Capital Holdings, Inc. | Crestview Partners II GP, L.P. | 13G/A | 6.3% | 4.1M |
| Feb 17, 2026 | INAB | IN8bio, Inc. | Alyeska Investment Group, L.P. | 13G | 9.9% | 966K |
| Feb 17, 2026 | MAS | Masco Corporation | HARRIS ASSOCIATES L P | 13G | 5.5% | 11.5M |
| Feb 17, 2026 | NMRA | Neumora Therapeutics, Inc. | K2 HealthVentures Equity Trust LLC | 13G/A | 5.0% | 9.0M |
| Feb 17, 2026 | RYTM | RHYTHM PHARMACEUTICALS, INC. | RA Capital Management, L.P. | 13G/A | 9.9% | 6.7M |
| Feb 17, 2026 | IMUX | Immunic, Inc. | Alyeska Investment Group, L.P. | 13G/A | 6.2% | 7.5M |
| Feb 17, 2026 | XXI | Cantor Equity Partners, Inc. | Citadel Securities GP LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | IE | Ivanhoe Electric Inc. | Alyeska Investment Group, L.P. | 13G | 5.3% | 7.7M |
| Feb 17, 2026 | N/A | Vine Hill Capital Investment Corp. II | Vine Hill Capital Sponsor II LLC | 13G | 25.0% | 7.7M |
| Feb 17, 2026 | ETSY | ETSY INC | Lone Pine Capital LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | ANRO | Alto Neuroscience, Inc. | K2 HealthVentures Equity Trust LLC | 13G/A | 2.4% | 789K |
| Feb 17, 2026 | AHT | ASHFORD HOSPITALITY TRUST, INC. | CastleKnight Master Fund LP | 13G/A | 6.4% | 411K |
| Feb 17, 2026 | HNGE | Hinge Health, Inc. | Bessemer Venture Partners X L.P. | 13G/A | 4.3% | 1.6M |
| Feb 17, 2026 | GWH | ESS Tech, Inc. | Alyeska Investment Group, L.P. | 13G | 7.1% | 1.4M |
| Feb 17, 2026 | RZLV | Rezolve AI plc | Citadel Advisors LLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | PALI | PALISADE BIO, INC. | RA Capital Management, L.P. | 13G/A | 9.9% | 15.7M |
| Feb 17, 2026 | CHA | Chagee Holdings Limited | COATUE MANAGEMENT, LLC | 13G/A | 2.7% | 3.2M |
| Feb 17, 2026 | SNCY | Sun Country Airlines Holdings, Inc. | Citadel Advisors LLC | 13G/A | 5.0% | 2.6M |
| Feb 17, 2026 | XPOF | Xponential Fitness, Inc. | MSD Partners, L.P. | 13G/A | 4.7% | 1.7M |
| Feb 17, 2026 | GUTS | Fractyl Health, Inc. | Alyeska Investment Group, L.P. | 13G/A | 5.0% | 7.6M |
| Feb 17, 2026 | SPAI | Safe Pro Group Inc. | Citadel Advisors LLC | 13G/A | 5.5% | 1.2M |
| Feb 17, 2026 | ZIP | ZIPRECRUITER, INC. | ArrowMark Colorado Holdings, LLC | 13G/A | 2.8% | 2.0M |
| Feb 17, 2026 | GRO | Brazil Potash Corp. | Alyeska Investment Group, L.P. | 13G | 9.9% | 5.3M |
| Feb 17, 2026 | LXEO | Lexeo Therapeutics, Inc. | Citadel Advisors LLC | 13G/A | 7.2% | 5.4M |
| Feb 17, 2026 | PRLB | Proto Labs Inc | DISCIPLINED GROWTH INVESTORS INC /MN | 13G/A | 11.3% | 2.7M |
| Feb 17, 2026 | ZD | ZIFF DAVIS, INC. | ArrowMark Colorado Holdings, LLC | 13G/A | 3.5% | 1.4M |
| Feb 17, 2026 | MNPR | Monopar Therapeutics Inc. | RA Capital Management, L.P. | 13G/A | 9.9% | 668K |
| Feb 17, 2026 | SPRB | Spruce Biosciences, Inc. | Citadel Advisors LLC | 13G/A | 6.5% | 70K |
| Feb 17, 2026 | CELH | Celsius Holdings, Inc. | William H. Milmoe | 13G/A | 6.0% | 15.4M |
| Feb 17, 2026 | TNDM | TANDEM DIABETES CARE INC | ArrowMark Colorado Holdings, LLC | 13G/A | 4.3% | 2.9M |
| Feb 17, 2026 | GDYN | GRID DYNAMICS HOLDINGS, INC. | Alyeska Investment Group, L.P. | 13G/A | 4.5% | 3.8M |
| Feb 17, 2026 | N/A | DBV Technologies S.A. | Citadel Advisors LLC | 13G/A | 3.1% | 7.4M |
| Feb 17, 2026 | EGHT | 8X8 INC /DE/ | SYLEBRA CAPITAL LLC | 13D/A | 7.2% | 10.0M |
| Feb 17, 2026 | SPT | Sprout Social, Inc. | ArrowMark Colorado Holdings, LLC | 13G/A | 7.0% | 3.7M |
| Feb 17, 2026 | SEDG | SOLAREDGE TECHNOLOGIES, INC. | Citadel Securities GP LLC | 13G/A | 3.4% | 2.1M |
| Feb 17, 2026 | ELUT | Elutia Inc. | Alyeska Investment Group, L.P. | 13G/A | 3.2% | 1.3M |
| Feb 17, 2026 | KDP | Keurig Dr Pepper Inc | HARRIS ASSOCIATES L P | 13G | 6.3% | 86.3M |
| Feb 17, 2026 | IPSC | Century Therapeutics, Inc. | Point72 Asset Management, L.P. | 13G/A | 6.8% | 6.0M |
| Feb 17, 2026 | NB | NioCorp Developments Ltd. | Citadel Advisors LLC | 13G/A | 0.0% | 36K |
| Feb 17, 2026 | PMVP | PMV Pharmaceuticals, Inc. | ArrowMark Colorado Holdings, LLC | 13G/A | 5.8% | 3.1M |
| Feb 17, 2026 | BFLY | Butterfly Network, Inc. | GLENVIEW CAPITAL MANAGEMENT, LLC | 13D/A | 6.3% | 14.3M |
| Feb 17, 2026 | DFLI | Dragonfly Energy Holdings Corp. | Alyeska Investment Group, L.P. | 13G | 9.9% | 1.2M |
| Feb 17, 2026 | MASS | 908 Devices Inc. | First Light Asset Management, LLC | 13G/A | 16.5% | 6.0M |
| Feb 17, 2026 | PCSC | Perceptive Capital Solutions Corp | Commodore Capital LP | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Point72 Asset Management, L.P. | 13G/A | 6.9% | 3.0M |
| Feb 17, 2026 | UONE | URBAN ONE, INC. | Citadel Securities GP LLC | 13G | 9.4% | 580K |